Showing results (491-500 of 649) with videos related to
Sort By:
Pageof 65
PPAR Research|April 2, 2016
PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose ToleranceJia Liu, Rui Lu, Ying Wang, et al.PPAR Research|July 26, 2017
2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical MastitisFernanda Rosa, Johan S Osorio, Erminio Trevisi, et al.PPAR Research|June 18, 2016
Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?Chiara Cilibrasi, Valentina Butta, Gabriele Riva, et al.PPAR Research|April 26, 2016
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling PathwaysWen-Ying Wei, Zhen-Guo Ma, Si-Chi Xu, et al.PPAR Research|December 10, 2015
Restoration of Endothelial Function in Pparα (-/-) Mice by TempolNeerupma Silswal, Nikhil Parelkar, Jon Andresen, et al.PPAR Research|March 14, 2019
Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System RegulationMaría Sánchez-Aguilar, Luz Ibarra-Lara, Leonardo Del Valle-Mondragón, et al.PPAR Research|January 30, 2007
Resolving the Two "Bony" Faces of PPAR-gammaBeata Lecka-Czernik, Larry J SuvaPPAR Research|December 7, 2007
RAR/RXR and PPAR/RXR Signaling in Spinal Cord InjurySabien van Neerven, Jörg MeyPPAR Research|May 17, 2008
PPAR Ligands for Cancer ChemopreventionYumiko Yasui, Mihye Kim, Takuji TanakaPPAR Research|May 24, 2008
A Role for PPARbeta/delta in Tumor Stroma and TumorigenesisRolf Müller, Martin Kömhoff, Jeffrey M Peters, et al.Pageof 65